POLYMERASE CAPITAL
Polymerase Capital is a venture capital firm focused on life science companies.
Similar Organizations
Hatteras BioCapital
Hatteras BioCapital is an investment advisory firm focused on clinical stage life science companies.
Salex Capital
Salex Capital
UG Capital
UG Capital
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-07 | Genascence | Polymerase Capital investment in Series A - Genascence | 10.5 M USD |
More informations about "Polymerase Capital"
Polymerase Capital investment portfolio - PitchBook
Polymerase Capital's latest investment was on 07-Jan-2022 in Genascence, a company within the Biotechnology industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
Polymerase Capital - Investments, Portfolio & Company Exits
Jan 7, 2022 Polymerase Capital has invested in Genascence on Jan 7, 2022. This investment - Series A - Genascence - was valued at . obfuscated. obfuscated. How many investments has …See details»
Polymerase Capital - VC Firm Profile - Gaebler.com Venture …
Founded in 2021, Polymerase Capital is a venture capital firm. The firm seeks to invest in seed and early-stage life science companies.See details»
Polymerase Capital - Zefyron Investor
Polymerase Capital is a venture capital firm focused on life science companiesSee details»
Polymerase Capital - LinkedIn
Polymerase Capital Venture Capital and Private Equity Principals FollowSee details»
Polymerase Capital - CB Insights
Polymerase Capital is venture capital firm that invests in life science firms. Use the CB Insights Platform to explore Polymerase Capital's full profile. Polymerase Capital Portfolio Investments, …See details»
Polymerase Capital investor portfolio, rounds & team
Polymerase Capital. Venture capital Claimed. Save Edit profile. Save. Overview. Portfolio (0) Notes. Recent News about Polymerase Capital Edit. Portfolio analysis ...See details»
Polymerase Capital - Crunchbase
Polymerase Capital is a venture capital firm focused on life science companies.See details»
Genanscence raises $10.5 million in Series A financing
May 10, 2022 In 2019, the company completed a seed round of finance led by Polymerase Capital. Filed Under: Rheumatology Tagged With: Genascence, GNSC-001, Pacira BioSciences . About The Author. Brian Buntz. As the …See details»
Genascence Announces First Close in Series A …
May 10, 2022 The company completed a seed round of financing in 2019 led by Polymerase Capital. GNSC-001 Phase 1 Clinical Trial Data to be Presented at the American Society for Gene & Cell Therapy 25 th Annual ...See details»
Polymerase Capital — 1 Investments, Performance analytics, Stats ...
Polymerase Capital. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of …See details»
Team - Genascence
He is Partner at Polymerase Capital, and currently serves on the boards of iRenix Medical (executive chairman), Ethris GmbH, and Chameleon Biosciences. Tom has been recognized …See details»
Polymerase Capital - Updates, News, Events, Signals & Triggers
Polymerase Capital is a venture capital firm focused on life science companies.See details»
Genascence Closes First $10.5M Tranche of Series A Financing
May 10, 2022 The round was led by Pacira BioSciences, with participation from Polymerase Capital, DeepWork Capital, and University of Florida Research Foundation.See details»
Genascence Company Profile 2024: Valuation, Funding & Investors …
United States Department of Defense, Deepwork Capital, Pacira BioSciences, University of Florida Research Foundation, and Polymerase Capital have invested in Genascence. Who are …See details»
Genascence Announces Completion of Dosing and Interim Safety …
May 5, 2021 The company completed a seed round of financing in 2019 led by Polymerase Capital. Genascence's founders and leadership team have deep experience in the design, …See details»
Polymerase Capital has 1 Investment in Genascence - Crunchbase
Funding Round search resultsSee details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 Primrose Bio, Inc. (“Primrose,” the “Company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in …See details»
Genascence - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 23, 2023: Grant - …See details»